Gilead Sciences (GILD) Income from Continuing Operations (2009 - 2026)

Gilead Sciences (GILD) has reported Income from Continuing Operations for 18 consecutive years, with 2021000000.0 the latest figure, recorded in Q1 2026.

• Income from Continuing Operations for Q1 2026 came in at 2021000000.0, up 53.69% year-over-year; the trailing twelve-month figure through Mar 2026 was 9562000000.0 (up 60.3% YoY), and the FY2025 annual result was 8510000000.0, up 1676.62% from the prior year.
• Income from Continuing Operations was 2021000000.0 for Q1 2026 at Gilead Sciences, down from 2528000000.0 in the prior quarter.
• Over five years, Income from Continuing Operations peaked at 3052000000.0 in Q3 2025 and troughed at 4171000000.0 in Q1 2024.
• Average Income from Continuing Operations over 5 years is 1266647058.82, with a median of 1615000000.0 recorded in 2024.
• Year-over-year, Income from Continuing Operations soared 8100.0% in 2023 and plunged 523.88% in 2024.
• Over 5 years, Income from Continuing Operations stood at 1633000000.0 in 2022, then retreated by 13.29% to 1416000000.0 in 2023, then increased by 25.85% to 1782000000.0 in 2024, then soared by 41.86% to 2528000000.0 in 2025, then retreated by 20.06% to 2021000000.0 in 2026.
• Per Business Quant data, the three most recent Income from Continuing Operations figures were 2021000000.0 in Q1 2026, 2528000000.0 in Q4 2025, and 3052000000.0 in Q3 2025.